Despite its clinical importance, effective treatment of liver fibrosis remains challenging due to its multifactorial and dynamic pathogenesis, which involves complex signaling pathways and pro-fibrotic mediators such as transforming growth factor-beta (TGF-β) (Roehlen et al., 2020). The gene discussed is TGFB1; the disease is Hepatic fibrosis.